Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis
about
Bipolar disorder and alcohol use disorder: a reviewAcamprosate for alcohol dependenceOpioid antagonists for alcohol dependencePharmacologic Interventions for Pregnant Women Enrolled in Alcohol TreatmentPharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.Improving clinical outcomes for naltrexone as a management of problem alcohol useThe clinical pharmacology of acamprosate.Targeted opioid receptor antagonists in the treatment of alcohol use disordersWorld Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.Packages of care for alcohol use disorders in low- and middle-income countries.The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.A mixed non-homogeneous hidden Markov model for categorical data, with application to alcohol consumption.Opioid modulators for alcohol dependence.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Treatment of the depressed alcoholic patient.Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy.New pharmacological approaches for the treatment of alcoholism.Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence.An inpatient treatment and discharge planning protocol for alcohol dependence: efficacy in reducing 30-day readmissions and emergency department visits.Neurodevelopmental liabilities in alcohol dependence: central serotonin and dopamine dysfunction.Acamprosate for the adjunctive treatment of alcohol dependence.A literature review of cost-benefit analyses for the treatment of alcohol dependence.Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.Effects of prazosin, an α1-adrenergic receptor antagonist, on the seeking and intake of alcohol and sucrose in alcohol-preferring (P) rats.Low-dose prazosin alone and in combination with propranolol or naltrexone: effects on ethanol and sucrose seeking and self-administration in the P rat.An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence.Assessing the efficacy of medical treatments for alcohol use disorders.Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals.Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans.Development of medications for alcohol use disorders: recent advances and ongoing challenges.Acamprosate in the treatment of alcohol dependence.Pharmacotherapy of alcohol use disorders.Prescription for antidepressant in reducing future alcohol-related readmission in patients suffering from depression and alcohol use disorder: a retrospective medical record reviewHow Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and WithdrawalSocial workers' knowledge and perceptions of effectiveness and acceptability of medication assisted treatment of substance use disordersEnhancing validity in co-occurring disorders treatment research.Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?Preclinical and clinical pharmacology of alcohol dependence.
P2860
Q22252584-3AB5AC4E-B0FC-4163-AE26-78111E591341Q24235594-F7CC986D-07D4-4475-AC43-D962E5874C31Q24235797-954B2C1B-F370-4818-8BB4-B8F9FF8B5FEEQ24239840-4EE58D25-A54B-49E7-993A-CC4DE677A822Q24793186-1CD9F5CA-BC8F-459C-AE58-876DBFCBB88BQ27021406-CCD4F9D5-E14C-44EE-9027-DCCAC7E32FADQ27687874-0780C335-EC24-4DA4-B7B9-8A03A506B03BQ28295125-CC0EB73A-9F8F-443E-8C35-22A11F4C8A99Q33319816-B98AC7F8-6C0A-4FAC-A497-8F827AD85E65Q33512908-788E1CA3-79B9-472E-B0B9-12EA84BE4534Q34088940-2BAFBB3E-E761-417A-8001-04AC4E7EC294Q34149677-48987A93-2FCA-4F15-A7AA-8F603D178B8AQ34190543-F6B3AE7A-8C5A-40A0-B01A-A99E54AC39C9Q34277168-BB7E339F-048D-4CEA-84AB-97E28965C3BEQ34295034-F9285AE5-9FE3-441C-ADDD-298944649037Q34306652-98A51828-162C-4F41-88C5-D34000CB8ACAQ34536749-737B219A-71F9-48D9-B123-6411824633BBQ34582243-E8C8F929-4934-4A57-AB2C-D464184F71BFQ35128787-2BE299DC-BEAF-463A-AD6F-B2C59C0A546EQ35152511-E99621BA-29C3-417C-B8CC-59E705779973Q35164057-B3662965-27B1-4C05-B737-1341F9D654E6Q35169452-621950FD-26D6-4229-9FCE-1C1999058597Q35195707-9BFC754E-FC68-408F-9399-26850C7B1574Q35490468-0476224C-0A49-47BA-BBCC-3DB75277D55EQ35670393-B091DD3E-EA48-41D9-A5E0-EBB321B1272EQ35858582-D0E82A84-EC57-461E-A342-6925569156C0Q35871868-E8C58F05-5F02-4188-A2EC-4B8D345CFFB5Q35906903-A620AAB0-D861-43CA-8472-21F6DBDF3F52Q36021630-F067A65C-62C1-43BA-AA7A-BD1A8BF87044Q36145330-741788BF-B79F-4B3F-BF22-6A13855E0F27Q36150622-7C2127C3-6C6A-45C4-9D13-A747CADF3E48Q36273459-D4885E7C-5954-4EFA-AFD9-B4B0FCDEFC2CQ36311029-32AB5CCE-7995-40F8-929B-1E50012ABBB6Q36393188-EE0C4BB1-771B-471B-A5E3-156488F5CEB3Q36460012-F6396847-2D9C-4792-977A-5A0E409CEFF6Q36533966-B5435453-E54D-4879-BA83-4DAD2A159FDFQ36540048-8DFFC3D5-C671-4AFA-836C-79542FD4AD85Q36556317-7F637231-3821-4EBA-9993-E8AD7CF0421BQ36664852-7B4A417C-A5CF-49AA-A32C-19FA01BCAABFQ36709633-83F7B5FC-908A-40C8-9D9B-53859AD1A972
P2860
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis
description
article
@en
im September 2001 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2001
@uk
ലേഖനം
@ml
name
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis
@en
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis
@nl
type
label
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis
@en
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis
@nl
prefLabel
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis
@en
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis
@nl
P2860
P1476
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis
@en
P2093
Henry R. Kranzler
Jeffrey Kirk
P2860
P304
P356
10.1111/J.1530-0277.2001.TB02356.X
P577
2001-09-01T00:00:00Z